CD138 Expression Helps Distinguishing Waldenström's Macroglobulinemia (WM) From Splenic Marginal Zone Lymphoma (SMZL)
- 1 February 2011
- journal article
- Published by Elsevier BV in Clinical Lymphoma Myeloma and Leukemia
- Vol. 11 (1), 99-102
- https://doi.org/10.3816/clml.2011.n.019
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Novel immunophenotypic features of marrow lymphoplasmacytic lymphoma and correlation with Waldenström's macroglobulinemiaLaboratory Investigation, 2009
- Mantle cell lymphoma with flow cytometric evidence of clonal plasmacytic differentiation: A case reportCytometry Part B: Clinical Cytometry, 2009
- Lymphoplasmacytic Lymphoma/Waldenstrom MacroglobulinemiaAdvances in Anatomic Pathology, 2005
- Serum syndecan‐1, basic fibroblast growth factor and osteoprotegerin in myeloma patients at diagnosis and during the course of the diseaseEuropean Journal of Haematology, 2004
- Clinicopathological definition of Waldenstrom's macroglobulinemia: Consensus Panel Recommendations from the Second International Workshop on Waldenstrom's MacroglobulinemiaSeminars in Oncology, 2003
- Immunophenotypic analysis of Waldenstrom's macroglobulinemiaSeminars in Oncology, 2003
- Waldenström MacroglobulinemiaAmerican Journal of Clinical Pathology, 2001
- A plasmocyte selective monoclonal antibody (B‐B4) recognizes syndecan‐1British Journal of Haematology, 1996
- B lymphocytes express and lose syndecan at specific stages of differentiation.Cell Regulation, 1989
- Incipient myelomatosis or «essential« hyperglobulinemia with fibrinogenopenia — a new syndrome?Acta Medica Scandinavica, 1944